TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35348351

Group type: EXPERIMENTAL
Intervention: Injectable norethisterone enanthate (Net‐En)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Etonorgesterol/ethinyl estradiol vaginal ring (NuvaRing)
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Oral contraceptives
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Persistent subclinical Candida colonization
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Presence of Candida hyphae
Number of subjects: 94

Group type: EXPERIMENTAL
Intervention: Subclinical Candida colonization
Number of subjects: 94
Study: 33176845

Group type: EXPERIMENTAL
Intervention: Ramosetron (0.3 mg IV)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg IV)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 122
Study: 33807285

Group type: EXPERIMENTAL
Intervention: Intervention aimed at improving information on cardiovascular risk; details on dosage and duration not specified
Number of subjects: 464

Group type: COMPARATOR
Intervention: Usual care; details not specified
Number of subjects: 464
Study: 33008479

Group type: EXPERIMENTAL
Intervention: Kampo medicine (kakkonto and shosaikotokakikyosekko) administered 2.5 g of KT and 2.5 g of SSKKS three times a day for 14 days in addition to conventional treatment.
Number of subjects: 150

Group type: COMPARATOR
Intervention: Conventional treatment with antipyretics, painkillers, or antitussives.
Number of subjects: 150
Study: 34852855

Group type: EXPERIMENTAL
Intervention: fMRI neurofeedback targeting self-blaming emotions
Number of subjects: 43

Group type: COMPARATOR
Intervention: Self-guided psychological intervention
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: fMRI neurofeedback
Number of subjects: 43

Group type: COMPARATOR
Intervention: Self-guided psychological strategies
Number of subjects: 43
Study: 34332796

Group type: EXPERIMENTAL
Intervention: Sof-Lex discs
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sof-Lex Spiral Wheels
Number of subjects: 72
Study: 32675606

Group type: EXPERIMENTAL
Intervention: Exercise therapy (Xinmiao treatment system, >3 days/week, >1 h/day)
Number of subjects: 99
Study: 616663253

Group type: EXPERIMENTAL
Intervention: Classroom-based crew resource management courses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulation-based crew resource management courses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of classroom and simulation-based courses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Qualitative data analysis
Number of subjects: 0
Study: 34397270

Group type: EXPERIMENTAL
Intervention: Low-molecular-weight heparin
Number of subjects: 60

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 60
Study: 34235853

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: Doing competitive sport
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: Sitting position
Number of subjects: 1075

Group type: EXPERIMENTAL
Intervention: Parental history of LBP
Number of subjects: 1075

Group type: COMPARATOR
Intervention: Weight of schoolbags
Number of subjects: 1075
Study: 32651298

Group type: COMPARATOR
Intervention: Aspirin 100 mg daily
Number of subjects: 27395

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 5 mg twice daily
Number of subjects: 27395

Group type: EXPERIMENTAL
Intervention: Rivaroxaban 2.5 mg twice daily plus aspirin
Number of subjects: 27395

Group type: EXPERIMENTAL
Intervention: Oral factor Xa inhibitors (combined analysis)
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Additional randomized controlled trials (16,177 participants)
Number of subjects: 27395
Study: 36379323

Group type: EXPERIMENTAL
Intervention: Self-monitoring
Number of subjects: 1093
Study: 33385624

Group type: EXPERIMENTAL
Intervention: Standard-dose protocol (120 kV, 100 mA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Ultra-low-dose protocol (80 kV, 10 mA)
Number of subjects: 76
Study: 32856058

Group type: EXPERIMENTAL
Intervention: Vitrified oocytes
Number of subjects: 1844

Group type: COMPARATOR
Intervention: Fresh oocytes
Number of subjects: 1844

Group type: EXPERIMENTAL
Intervention: Vitrified oocytes with efficiency taken into account
Number of subjects: 1844

Group type: EXPERIMENTAL
Intervention: Vitrified oocytes with 100% post-warming survival
Number of subjects: 1844

Group type: COMPARATOR
Intervention: Fresh oocytes with 100% post-warming survival
Number of subjects: 1844
Study: 33611671

Group type: EXPERIMENTAL
Intervention: Daily ultra-low-dose prednisolone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily low-dose prednisolone for a week during acute viral infection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower doses of corticosteroids for treating relapses
Number of subjects: 0
Study: 32976954

Group type: EXPERIMENTAL
Intervention: fPIP (4-session psychodynamic-based focused parent-infant psychotherapy)
Number of subjects: 154

Group type: COMPARATOR
Intervention: TAU (standard pediatric care)
Number of subjects: 154
Study: 35605678

Group type: EXPERIMENTAL
Intervention: Saroglitazar (4 mg)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Fenofibrate (160 mg)
Number of subjects: 82
Study: 33045334

Group type: EXPERIMENTAL
Intervention: 650 mg acetaminophen every 6 hours for pain, with 5 mg/325 mg oxycodone-acetaminophen for breakthrough pain
Number of subjects: 80

Group type: COMPARATOR
Intervention: 5 mg/325 mg oxycodone-acetaminophen prescribed as 1 to 2 tablets every 6 hours as needed for pain (standard of care)
Number of subjects: 80
Study: 32369570

Group type: EXPERIMENTAL
Intervention: Nonsurgical mechanical debridement with adjunct low-level laser therapy (LLLT)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Nonsurgical mechanical debridement alone
Number of subjects: 67
Study: 34144529

Group type: EXPERIMENTAL
Intervention: Withania somnifera (Ashwagandha) 6 gm in powder form or extracts in tablets, or 500-1000 mg capsule for 8-12 weeks
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study: 33257489

Group type: EXPERIMENTAL
Intervention: Flurbiprofen axetil
Number of subjects: 420

Group type: COMPARATOR
Intervention: No NSAIDs (control group)
Number of subjects: 420
Study: 35766272

Group type: EXPERIMENTAL
Intervention: Average of baseline and 1-year BNP concentration
Number of subjects: 6740

Group type: EXPERIMENTAL
Intervention: Doubling of average BNP concentration
Number of subjects: 6740

Group type: EXPERIMENTAL
Intervention: Cardiovascular mortality rate
Number of subjects: 6740
Study: 32228146

Group type: EXPERIMENTAL
Intervention: Decentralised screening sites added in low-income neighbourhoods
Number of subjects: 0

Group type: COMPARATOR
Intervention: Screening invitation
Number of subjects: 0
Study: 32816872

Group type: EXPERIMENTAL
Intervention: Supervised progressive sprint interval training (SIT) (4‐6×30 s at maximum effort)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Moderate‐intensity continuous training (MICT) (40‐60 min at 60% of maximal aerobic capacity (VO 2peak))
Number of subjects: 54
Study: 33233972

Group type: EXPERIMENTAL
Intervention: Computerised word finding therapy plus usual care
Number of subjects: 278

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 278

Group type: COMPARATOR
Intervention: Usual care plus attention control
Number of subjects: 278
Study: 35483248

Group type: EXPERIMENTAL
Intervention: Self-referent task (n = 230)
Number of subjects: 450

Group type: COMPARATOR
Intervention: Other-referent task (n = 220)
Number of subjects: 450
Study: 32880909

Group type: EXPERIMENTAL
Intervention: Ixekizumab
Number of subjects: 1027

Group type: COMPARATOR
Intervention: Guselkumab
Number of subjects: 1027
Study: 34668068

Group type: EXPERIMENTAL
Intervention: Laparoscopic-guided local anesthetic infiltration technique (LDAI)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Ultrasound-guided transversus abdominis plane block (US-TAP)
Number of subjects: 62
Study: 35332504

Group type: EXPERIMENTAL
Intervention: Tele-yoga training
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 32
Study: 34247896

Group type: EXPERIMENTAL
Intervention: Combined high-dose intensity-modulated radiotherapy and ADT (6 months)
Number of subjects: 67
Study: 33878855

Group type: EXPERIMENTAL
Intervention: Combination of zinc and arginine (lotion A)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (lotion B)
Number of subjects: 40
Study: 35211189

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (Dex)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 65
Study: 33645313

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Mindfulness training
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79

Group type: COMPARATOR
Intervention: Relaxation control
Number of subjects: 79
Study: 32406924

Group type: EXPERIMENTAL
Intervention: Mediterranean diet adherence
Number of subjects: 8647

Group type: EXPERIMENTAL
Intervention: Metabolic signature
Number of subjects: 8647

Group type: EXPERIMENTAL
Intervention: Metabolic signature adjusted for MEDAS scores
Number of subjects: 8647

Group type: EXPERIMENTAL
Intervention: Genetically inferred metabolic signature
Number of subjects: 8647
Study: 34341321

Group type: EXPERIMENTAL
Intervention: Enhanced video education session
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 120
Study: 33136654

Group type: EXPERIMENTAL
Intervention: Multi-modal isometric exercise intervention (MIET); 3 sessions per week of 4, 2-min isometric contractions with 1-min rest for 6 weeks.
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (CON); no specific intervention details provided.
Number of subjects: 20
Study: 33095777

Group type: EXPERIMENTAL
Intervention: Pre-operative home-based exercise therapy with one exercise
Number of subjects: 0
Study: 33650634

Group type: EXPERIMENTAL
Intervention: Ferric maltol (FM)
Number of subjects: 250

Group type: COMPARATOR
Intervention: IV iron (IV FCM)
Number of subjects: 250
Study: 32553767

Group type: EXPERIMENTAL
Intervention: Operations performed at the highest volume centers
Number of subjects: 22739

Group type: COMPARATOR
Intervention: Operations performed at the lowest volume hospitals
Number of subjects: 22739

Group type: EXPERIMENTAL
Intervention: Postoperative complications
Number of subjects: 22739
Study: 36167555

Group type: EXPERIMENTAL
Intervention: Anti-pseudomonal antibiotic treatment with intravenous beta-lactam and oral ciprofloxacin for 14 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: No antibiotic treatment
Number of subjects: 150
Study: 34633418

Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) therapy
Number of subjects: 172

Group type: COMPARATOR
Intervention: Conventional therapy (continuous subcutaneous insulin infusion or multiple daily insulin injections with or without CGM)
Number of subjects: 172
Study: 33152805

Group type: EXPERIMENTAL
Intervention: mental illness anti-stigma curriculum
Number of subjects: 751

Group type: EXPERIMENTAL
Intervention: contact with 2 young adults with mental illness
Number of subjects: 751

Group type: COMPARATOR
Intervention: merged control (printed materials/no intervention)
Number of subjects: 751
Study: 33328035

Group type: EXPERIMENTAL
Intervention: Remote Patient Management (RPM) intervention
Number of subjects: 1538

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 1538

Group type: EXPERIMENTAL
Intervention: Combined data from RPM group
Number of subjects: 1538

Group type: COMPARATOR
Intervention: Combined data from UC group
Number of subjects: 1538
Study: 33112655

Group type: EXPERIMENTAL
Intervention: High-GI breakfast (GI=71)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Low-GI breakfast (GI=40)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Breakfast omission
Number of subjects: 10
Study: 35446292

Group type: EXPERIMENTAL
Intervention: Cluster nursing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine nursing
Number of subjects: 0
Study: 32935564

Group type: COMPARATOR
Intervention: SWL (n=29)
Number of subjects: 202

Group type: COMPARATOR
Intervention: URS (n=43)
Number of subjects: 202

Group type: COMPARATOR
Intervention: URS + 4.8F DJS (n=39)
Number of subjects: 202

Group type: COMPARATOR
Intervention: URS + 6F DJS (n=42)
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control (n=30)
Number of subjects: 202
Study: 32503654

Group type: EXPERIMENTAL
Intervention: irinotecan + ketogenic diet
Number of subjects: 518

Group type: COMPARATOR
Intervention: irinotecan + normal diet
Number of subjects: 518
Study: 35987538

Group type: EXPERIMENTAL
Intervention: Immediate-app use group (iApp; n=25), using the mobile application for 4 min a day for 12 days (T0-T1)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Delayed-app group (dApp; n=20), starting the mobile application at T1 and using it for 12 consecutive days (T1-T2)
Number of subjects: 55
Study: 34186232

Group type: EXPERIMENTAL
Intervention: Narrative Exposure Therapy (NET) and personalized psychological intervention
Number of subjects: 111

Group type: COMPARATOR
Intervention: Personalized psychological intervention (Control)
Number of subjects: 111
Study: 34265388

Group type: EXPERIMENTAL
Intervention: Intra-articular injections of PBSCs plus HA after arthroscopic subchondral drilling
Number of subjects: 69

Group type: COMPARATOR
Intervention: HA plus physiotherapy
Number of subjects: 69
Study: 36282771

Group type: EXPERIMENTAL
Intervention: Open-label ziprasidone (20-80 mg twice a day) for up to 26 weeks
Number of subjects: 23
Study: 33661822

Group type: EXPERIMENTAL
Intervention: Gender-based stigma at baseline
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Psychological distress at 4 months
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Poor social support at 4 months
Number of subjects: 233
Study: 35063224

Group type: EXPERIMENTAL
Intervention: Ketogenic diet (KD) initiated within 8-33 hours (average 23 hours) of hospital admission.
Number of subjects: 10
Study: 32814506

Group type: EXPERIMENTAL
Intervention: GLU (1.2 g·min‐1 dextrose alone)
Number of subjects: 8

Group type: COMPARATOR
Intervention: GLU+CAL (1.2 g·min‐1 dextrose with 2000 mg calcium)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GLU
Number of subjects: 8

Group type: COMPARATOR
Intervention: GLU+CAL
Number of subjects: 8
Study: 35502897

Group type: EXPERIMENTAL
Intervention: Muscarinic acetylcholine receptor antagonist biperiden
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Dopamine D2/D3 receptor antagonist amisulpride
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Galantamine (elevates acetylcholine levels)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Levodopa (elevates dopamine levels)
Number of subjects: 81
Study: 33499830

Group type: EXPERIMENTAL
Intervention: Video-led educational intervention conducted by medical students
Number of subjects: 0

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 0
Study: 35255811

Group type: EXPERIMENTAL
Intervention: 300 g/d probiotic yogurt containing 106 cfu/g of Lactobacillus acidophilus and Bifidobacterium lactis strains
Number of subjects: 68

Group type: COMPARATOR
Intervention: 300 g/d plain yogurt
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Probiotic yogurt
Number of subjects: 68
Study: 33416608

Group type: EXPERIMENTAL
Intervention: Point-of-care (POC) hemoglobin A1c testing
Number of subjects: 1771
Study: 616655105

Group type: EXPERIMENTAL
Intervention: Remifentanil/propofol
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol/isoflurane
Number of subjects: 60
Study: 35100594

Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg d‐1 + diclofenac Na 100 mg tab (to be taken only during colic episodes)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Tamsulosin HCL 0.4 mg cap + diclofenac Na 100 mg tab (to be taken only during colic episodes)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Diclofenac Na 100 mg tab only (to be taken only during colic episodes)
Number of subjects: 90
Study: 33831805

Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) + Cervical stabilization exercise (CSE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Classical massage (CM) + Cervical stabilization exercise (CSE)
Number of subjects: 0
Study: 35908546

Group type: EXPERIMENTAL
Intervention: MLC601 (combination of various herbal and non‐herbal components)
Number of subjects: 533

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 533
Study: 34626890

Group type: EXPERIMENTAL
Intervention: In vivo exposure therapy (IVET) for 5 weeks
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham physical activity (PA) monitoring for 5 weeks
Number of subjects: 12
Study: 33587369

Group type: EXPERIMENTAL
Intervention: HARK (Hyaluronic Acid Filler)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (HAJV)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HARK
Number of subjects: 0
Study: 36054131

Group type: EXPERIMENTAL
Intervention: Dairy milk (DM) - consumed twice daily (30g protein/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exercise and dairy milk (EX+DM) - 12 weeks whole-body PRT program (x3 sessions/week) and dairy milk (30g protein/day)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Exercise alone (EX) - 12 weeks whole-body PRT program (x3 sessions/week)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (CON) - ad libitum dietary and exercise habits
Number of subjects: 32
Study: 34903999

Group type: EXPERIMENTAL
Intervention: Combination of CoQ10 (200 mg) + ALA (250 mg) + ALCAR (250 mg) orally twice daily for two weeks
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 33569814

Group type: EXPERIMENTAL
Intervention: TASeFALL (email-based questionnaire)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (monthly paper-based questionnaire)
Number of subjects: 40
Study: 33211921

Group type: EXPERIMENTAL
Intervention: Dietary supplement with calcium (200 mg daily), vitamin D3 (600 IU), and vitamin B6 (2 mg) for 12 months in group 1.
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Dietary supplement with calcium (200 mg daily), vitamin D3 (600 IU), and vitamin B6 (2 mg) for 12 months in group 2.
Number of subjects: 119

Group type: COMPARATOR
Intervention: Control group (no dietary supplement) in group 3.
Number of subjects: 119
Study: 35420668

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32606059

Group type: EXPERIMENTAL
Intervention: Reactive balance training (RBT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aerobic and strength training (AST)
Number of subjects: 0
Study: 35112166

Group type: EXPERIMENTAL
Intervention: FEC-100
Number of subjects: 0

Group type: COMPARATOR
Intervention: AC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 32752932

Group type: EXPERIMENTAL
Intervention: M207 3.8 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35943913

Group type: EXPERIMENTAL
Intervention: Closed incision negative pressure therapy (ciNPT)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Adhesive strips (AS)
Number of subjects: 75
Study: 35902887

Group type: EXPERIMENTAL
Intervention: Brolucizumab (6 mg/50 µL)
Number of subjects: 114

Group type: COMPARATOR
Intervention: Aflibercept (2 mg/50 µL)
Number of subjects: 114
Study: 32321052

Group type: EXPERIMENTAL
Intervention: SRP + PRGF
Number of subjects: 26

Group type: COMPARATOR
Intervention: SRP alone
Number of subjects: 26
Study: 35842616

Group type: EXPERIMENTAL
Intervention: Mum2BMoodBooster intervention
Number of subjects: 27
Study: 33984247

Group type: EXPERIMENTAL
Intervention: No delay (0 hours)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 1-hour delay
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 3-hour delay
Number of subjects: 24
Study: 32758299

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 100 mg/m2 (arm A)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 (arm B)
Number of subjects: 160
Study: 35238940

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg daily
Number of subjects: 6609

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6609
Study: 36239189

Group type: EXPERIMENTAL
Intervention: Allogenic FMT (from healthy lean donor)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Autologous FMT (their own stool)
Number of subjects: 28
Study: 33602399

Group type: EXPERIMENTAL
Intervention: PVI+PWI using cryoballoon
Number of subjects: 110

Group type: COMPARATOR
Intervention: PVI using cryoballoon
Number of subjects: 110
Study: 32879333

Group type: EXPERIMENTAL
Intervention: Baseline serum Midkine (MDK)
Number of subjects: 499
Study: 35867857

Group type: EXPERIMENTAL
Intervention: Study group (n=39) with additional interventions: local anesthetic infiltration, IV dexmedetomidine, IV ketamine, additional IV dexamethasone, and repeated adductor canal block injections
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (n=39) with standard multimodal analgesic regimen
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Study group (n=39)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (n=39)
Number of subjects: 78
Study: 34352145

Group type: EXPERIMENTAL
Intervention: Ball abutment (Group B)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dome abutment (Group A)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both abutments
Number of subjects: 12
Study: 33105357

Group type: EXPERIMENTAL
Intervention: Integrative neuromuscular training (INT) warm-up (n = 97)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Conventional warm-up (n = 93)
Number of subjects: 190
Study: 616522947

Group type: EXPERIMENTAL
Intervention: Test formulation (25-mg agomelatine)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Reference formulation (25-mg agomelatine)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Test and Reference formulations
Number of subjects: 60
Study: 35075225

Group type: EXPERIMENTAL
Intervention: Ultrasound imaging group (n=15)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group (n=14)
Number of subjects: 29
Study: 33619550

Group type: EXPERIMENTAL
Intervention: Pertuzumab plus trastuzumab and standard chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus trastuzumab and standard chemotherapy
Number of subjects: 0
Study: 32228427

Group type: EXPERIMENTAL
Intervention: Chamomile oil inhalation
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo inhalation
Number of subjects: 128
Study: 34927554

Group type: EXPERIMENTAL
Intervention: Physical Activity and Ergonomics Improvement Program (PAEIP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120